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Background: Universal developmental surveillance programs aimed at early identification and targeted early
intervention significantly improve short- and long-term outcomes in children at risk of developmental disorders.
However, a significant challenge remains in providing sufficiently rigorous research and robust evidence to inform
policy and service delivery. This paper describes the methods of the ‘Watch Me Grow’ study that aims to maximise
accurate early detection of children with developmental disorders through a partnership formed between policy
makers, service providers and researchers.
Methods/Design: A mixed methods study design was developed consisting of: (1) a qualitative study of parents
and health service providers to investigate barriers and enablers of developmental surveillance; (2) recruitment of a
birth cohort and their longitudinal follow-up to 18 months of age to: a) assess risk factors for not accessing existing
developmental surveillance programs and b) estimate the prevalence of children identified with developmental
risk; (3) comparison of surveillance outcomes with a reference standard at 18 months of age to assess the diagnostic
test accuracy of existing and alternative developmental surveillance tools; and (4) comparison of developmental
surveillance models to inform policy recommendations. Data linkage will be used to determine the uptake and
representativeness of the study participant group versus non-participants.
Discussion: The Watch Me Grow study is expected to provide a collaborative opportunity to enhance universal
developmental surveillance for early accurate identification of developmental risk. This will also provide quality
evidence about identification of developmental risk and access to services to be embedded in existing practice with
linkages to policy development.
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Importance of Universal Surveillance
There is increasing evidence that early detection and
intervention for developmental disorders has the potential
to alter adverse development and provide significant
short- and long-term benefits to human capacity.
These benefits include increased school retention and
reduced unemployment [1-3]. Unfortunately, the majority
of developmental difficulties are not detected until children
start school [3]. The Australian National Health and
Medical Research Council [4] and the American
Academy of Paediatrics (AAP) [5] recommend a system of
universal developmental surveillance where the risk of
significant developmental problems, and the need for
further assessment and early intervention, can be
identified early. Developmental surveillance is a continuous
and cumulative process whereby knowledgeable healthcare
professionals identify children who may have developmen-
tal problems [5]. The key components of developmental
surveillance include eliciting and attending to parents’
concerns about their child’s development; documenting
and maintaining a developmental history; making accurate
observations of the child; identifying risk and protective
factors; and maintaining an accurate record of findings. It
is critical that there is ongoing contact with families
and children coupled with anticipatory guidance and
promotion of child development within families as well as
responding to developmental concerns reported by par-
ents, followed by clinical observation and the use of a vali-
dated surveillance tool over multiple time periods [4,5].
What is currently known about Universal Surveillance
methods?
Reviews of current practice in primary healthcare
and anecdotal Australian evidence suggest that there
is inconsistency in how developmental surveillance is
undertaken in primary healthcare [6,7]. Studies have
documented the difficulties with approaches to monitoring
developmental progress in child health settings [8], which
typically involve parents/carers raising concerns during a
consultation, and/or the administration of screening tools.
While there are benefits of surveillance, there are also
barriers to developmental surveillance achieving its
potential positive impact. These include time constraints
and difficulties in accessing high quality and affordable
primary healthcare for children according to need [9], and
obstacles for children receiving appropriate interventions
even when they are recognised as being at risk of develop-
mental delay [10-13]. For example, in Australia there are
long waiting periods for both private and public assessment
and intervention services for identified developmental
problems such as speech and language disorders or
global developmental delay [14]. Moreover, the lack of data
regarding the uptake of the developmental surveillanceprogram and service utilisation creates challenges for
policy makers, service providers, and clinicians in develop-
ing appropriate care pathways; a key issue that the 'Watch
Me Grow' (WMG) study seeks to address [15].
We are not aware of any robust, longitudinal evidence
on the uptake of universal developmental surveillance in
communities, particularly those with high levels of
socioeconomic disadvantage. Additional gaps in existing
evidence include the nature of the barriers and enablers to
the uptake of developmental surveillance by families and
the accuracy of developmental surveillance in identifying
children at risk of developmental disorders such as autism
spectrum disorder (ASD) [16,17] and intellectual disability.
Finally, there is scant data regarding models of partnership
between policy makers and service providers to meet the
challenges in delivering universal or targeted interventions
for those at risk.
Developmental Surveillance in New South Wales
In 2007, the New South Wales (NSW) Ministry of Health
introduced the Parents’ Evaluation of Developmental Status
(PEDS) [18] for routine administration as a surveillance
tool to be completed by child health professionals such as a
Child and Family Health Nurse (what we will refer to as a
community nurse in this paper) or by general practitioners
(GPs). The PEDS is a 10-item standardised parent-report
questionnaire that systematically elicits parental concerns
regarding their child’s health, development, and behaviour
to estimate that child’s developmental risk [5,19]. The PEDS
has moderate reported sensitivity of 74–80%, and specificity
of 70–80% in validation studies from the USA [20],
however to our knowledge no diagnostic test accuracy study
has yet been conducted within Australia, notwithstanding a
small study examining the PEDS’ capacity to detect
symptoms of ASD [21]. The PEDS is designed for
completion by parents/carers of children from birth to
7 years and 11 months of age. It takes about two minutes
to administer. Of the ten questions, eight cover expressive
and receptive language, fine motor, gross motor, behaviour,
socialisation, self-care, and learning while the other two are
about more general learning, development, and behaviour.
Parents can respond ‘yes’, ‘a little’, or ‘no’. Two or more
predictive concerns places a child at high developmental
risk; one predictive concern places a child at moderate
developmental risk, and one or more non-predictive
concerns or no concerns places a child at low or no risk
[22]. In NSW, the Department of Health recommends that
children at high and moderate developmental risk are
further assessed by a child health professional using a
secondary developmental screening tool, the Ages and
Stages Questionnaire (ASQ) [23] and Ages and Stages
Questionnaire: Social-Emotional (ASQ:SE) [24].
In NSW, the PEDS is included in the child’s Personal
Health Record (PHR; commonly known as the ‘Blue Book’),
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be completed at regular check-ups (at 6 months, 12 months,
18 months, 2 years, 3 years and 4 years). In Australia,
developmental surveillance varies among states and
territories. The PEDS is now the first line developmental
surveillance tool used in many states and territories of
Australia, including NSW, Victoria, Tasmania, the
Australian Capital Territory, Western Australia and
urban areas of the Northern Territory. In South
Australia, the ASQ is used for developmental surveillance.
The ASQ is also used in NSW and Western Australia as
the second tier developmental surveillance tool as
described above, while in Victoria and the Northern
Territory the Brigance Screens [25] are used to follow-up
developmental risk detected by the PEDS. In Queensland,
community nurses conduct developmental reviews, but
standardised tools are not used. In addition, the Queensland
primary care program, which is run by nurses, targets
families who are identified as high risk, mainly through
the child’s first two years of life.
There are also significant between- and within-state
differences with regard to pathways to diagnostic assess-
ment following identification of children at developmental
risk. For example, in NSW, the subsequent assessment
depends on the pathway developed by areas within local
health districts, and can include referral to a paediatrician,
GP or a local child development clinic.
In addition to the issues inherent in the choice of
tools, procedures and follow-up pathways, there are also
significant barriers and enablers relating to health
systems and policies as well as in parental behaviours
that influence the uptake and participation in surveillance
programs. Based on a national survey in the USA, the
AAP reported that while most paediatricians agreed that
developmental issues should be addressed, they were less
confident about their ability to undertake this activity [26].
This survey identified a number of barriers for health
professionals in completing developmental monitoring,
including time constraints, inadequate reimbursement,
lack of non-physician support staff, lack of further diagnos-
tic and treatment services, insufficient training, and lack of
familiarity with assessment tools. In Australia a survey of
GPs in central and south western Sydney identified that less
than half (44%) use the NSW Blue Book which includes the
PEDS to discuss developmental concerns with parents [27].
At the same time, 60% of GPs who were surveyed reported
that there were barriers to families seeking help for their
children at risk of developmental disorders. These barriers
included waiting times, cost, availability and access to ser-
vices, and being from a non-English speaking back-
ground [27]. Using a case scenario method in which a
developmental paediatrician considered a 2.5-year-old
child as needing further follow-up, a study observed
that one fifth of GPs responded that they would notinitiate further assessment [27]. In this regard, the uptake
of current developmental surveillance methods appears to
be poor.
Unfortunately, families with the greatest needs for
basic services such as food, housing and healthcare are often
the least likely to receive support because of difficulties
encountered in accessing these basic services [28]. These
families are also likely to have children with a higher than
average risk of having a developmental or behavioural
difficulty. Furthermore, the predominant needs of children
with developmental or behavioural problems including
developmental assessment, speech and language therapy,
and support for parents in managing challenging behav-
iours, are often limited in disadvantaged areas, making it
difficult for families to access these services [29].Methodological considerations for the Watch Me Grow
study
To date, studies providing evidence about surveillance
programs have provided key pieces of information, but in
a way that has been disconnected from other information
that is required. This has been because study design was
cross-sectional rather than longitudinal, only quantitative
or qualitative rather than both, and often not embedded
within a service system. These are key methodological
limitations in the existing literature that form part of the
rationale for the WMG study.Methods/Design
Aims
Within the WMG study, our objectives are to:
1. examine barriers and enablers for universal
developmental surveillance in NSW from the
perspective of policies, systems and processes using
focus groups and in-depth interviews of
stakeholders.
2. assess risk factors for non-completion of 6-, 12-, and
18-month developmental surveillance from the per-
spective of parent participation and engagement;
3. determine the prevalence and psychosocial
correlates of developmental risk at these ages; and
4. ascertain the diagnostic test accuracy of the current
NSW universal developmental surveillance program
and whether the addition of an autism specific
screening tool at 18 months increases diagnostic
accuracy.
The WMG study is a mixed methods study that includes
both quantitative and qualitative components. The
qualitative component is designed to evaluate the feasibility,
and barriers and enablers of the current universal sur-
veillance program in NSW (objective 1), whereas the
Eapen et al. BMC Pediatrics 2014, 14:234 Page 4 of 9
http://www.biomedcentral.com/1471-2431/14/234quantitative component seeks to provide data addressing
objectives 2, 3 and 4.
Setting
This study is being conducted in south western Sydney,
an area of significant social disadvantage about 40 km
from the Sydney central business district. The South
Western Sydney Local Health District (SWSLHD)
provides tertiary (including neonatal intensive care,
inpatient and outpatient paediatric care) and community
health services to the residents of this region. Children are
referred to the Sydney Children’s Hospital Network for
subspecialist paediatric services. SWSLHD is the largest
health service in NSW and comprises seven local govern-
ment areas. In 2011, the population of SWSLHD was esti-
mated at 875,384 persons (11.7% of the NSW population),
and is projected to increase by 18,000 people per annum
over the next decade. By 2016, the population is expected
to reach 958,397 people and 1.06 million by 2021. There
were 12,997 births in south western Sydney in 2012,
representing about 13 per cent of all births in NSW [30].
The total fertility rate ranges from 1.90 to 2.34 infants per
woman compared to the NSW rate of 1.97 infants per
woman [31]. This is a fast growing population including a
large indigenous and culturally and linguistically diverse
(CALD) community, characterised as having high un-
employment, and the accompanying health and psycho-
social concerns of disadvantaged populations [31].
Study design
Objective 1: qualitative study
Participants in this component of the study will comprise
the main stakeholders, namely parents, community
nurses, GPs, paediatricians, general practice nurses,
pharmacy nurses, pre-school and day-care staff. We
will conduct focus groups as well as in-depth individual
interviews with participants to identify barriers to the
universal developmental surveillance program, community’s
awareness, accessibility and engagement with the surveillance
program as well as the factors that might enable universal
developmental surveillance. Parental knowledge about
typical/atypical early childhood development and profes-
sional knowledge about developmental surveillance systems
will also be ascertained. Participants from a range of socio-
economic and CALD backgrounds will be included in order
to ensure that we fully capture the experiences including
barriers and enablers to using the health services of families
from a wide range of ethnic and language backgrounds. We
will interview families from the main multicultural groups
resident in south western Sydney, and use translations of
study information and interpreters during this key stage.
The Grounded Theory Method will guide the interpret-
ation and thematic analyses of these qualitative data as well
as feed into hypotheses of later stages of the study [32].Objectives 2 and 3: longitudinal study
A cohort of children will be recruited in three main
study arms (see Figure 1). A birth cohort from two
teaching hospitals in SWSLHD will form the primary
target sample (birth arm). An additional prospective
cohort will be recruited through community nurses in
the community as this is the pathway being used
currently in NSW for developmental surveillance
(community nurse arm). These two study arms will
be combined into the main prospective cohort of the
study (prospective cohort). In addition, a retrospective
arm of the study will recruit infants born in the two
teaching hospitals that are currently in the age range
of 18 to 21 months (retrospective cohort) and will serve as
a comparison group.
For the birth arm, the WMG research team will attend
the postnatal wards on a daily basis to recruit mothers
who have given birth in the previous 24 hours at the two
teaching hospitals in SWSLHD. The nursing staff on the
postnatal wards will be consulted and their support
sought for recruitment into the study. Recruitment
information will be made available in English, Arabic,
Vietnamese, Khmer, and Chinese - the predominant
community languages used in south western Sydney.
Families who agree to participate in the study will be
asked to complete a Newborn Baseline Questionnaire
(NBQ) which includes baseline sociodemographic and
health service-use information, and will be informed about
the subsequent follow-up telephone interviews when their
infant is 6, 12, and 18 months of age.
For recruitment to the community nurse arm, parents
will be informed about the study by community nurses
during the Universal Health Home Visit that occurs by
four weeks post-birth. If the family shows interest in
learning more about the study, the contact information of
parents who express interest will be provided to the WMG
study research team. Researchers will then contact these
parents and mail study information and consent forms with
reply-paid envelopes to be returned.
The retrospective arm of the study will comprise infants
born in the two teaching hospitals who are in the age
range of 18 to 21 months at the time of recruitment. This
sample of children will serve as a ‘surveillance as usual in
the community’ comparison group (i.e., a control group).
This will help to determine any participation bias by
ensuring that the WMG study is not influencing the
help seeking and health related behaviours of study
participants via a Hawthorne effect. For example, it is
possible that the awareness gained through participation
in the study might make the families more compliant
with the developmental surveillance programs being
assessed.
The total target sample for the study from all three
arms is expected to be 2000 children.
Figure 1 Watch Me Grow study recruitment.
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interviews for the prospective cohort (i.e. those recruited
through the birth and community nurse arms of the
study) will consist of a 10-minute interview that will ask
about their use of universal developmental screening
services using a purposively developed Prospective
Developmental Surveillance Questionnaire (PDSQ). These
telephone interviews will occur after the infants reach 6,
12, and 18 months of age. The key questions will include
whether the child has been taken for the recommended
scheduled checks, which health service(s) has been
used, satisfaction level with the service, whether a
PEDS had been completed, and by whom. The researcher
contacting the family for the follow-up calls will complete
the PEDS with any parent who has not completed a PEDS
as part their child’s personal health record developmental
surveillance schedule. At the 18-month telephone call,
components of the NBQ will be re-administered so
that it is possible to compare the sociodemographic
characteristics at the child’s birth and 18 months
later, as well as further questions on social capital,
access to early childhood education services, and
parenting. The same procedures will be followed for the
retrospective cohort, but all the data will be collected
in one telephone call.Underlying theoretical model and data analysis for
longitudinal study In order to plan comprehensive
service models from the findings of the longitudinal
study, we need to examine the complex transactional
relationship between the child’s environment and biology
over time [33]. We have developed a composite of a
bio-ecological and life course model to serve as a frame-
work within which to do this [34-37]. These theoretical
models will be linked to appropriate analytical models and
in this regard multilevel modelling will be employed to
examine the independent impacts of community variables
(e.g., socio-economic status), parental/family variables
(e.g., family health, substance use, mental health history,
country of birth, language spoken at home, parental
perceptions about preventive healthcare and access to
childcare and preschools), and child variables (e.g.,
temperament, preterm/low birth weight, intrauterine
exposure to drugs, medicines, infections, low Apgar scores,
perinatal complications, presence of developmental and
behavioural concerns) on developmental risk and access to
services. A combined risk index will be created that
includes measures of biological, psychosocial, developmen-
tal and socioeconomic risk used in the previous multivari-
ate analyses. Cumulative risk analysis will be undertaken to
determine the relationship between burden of risk and
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services. In addition, we will examine the transactional
impacts of these variables on the uptake of referral
recommendations provided by the research team following
the reference standard assessment and utilisation of
health services.
Objective 4: diagnostic test accuracy study
All children who are identified as being at risk of having
a developmental disorder using the PEDS (both ASQ
positive and ASQ negative), will be invited to participate
in a reference standard assessment (defined below)
between 18 and 21 months of age. Of the approximately
2000 children that will be recruited to the study, it is
estimated that a concern on the PEDS will be reported for
around 800 children (40%) and of these approximately half
(400 children) will be at a level of risk that warrants
further assessment using the ASQ and the ASQ:SE. From
the remaining 1200 PEDS negative children, every 12th
child (n = 100) will also be invited to participate in all
the additional assessments (ASQ, ASQ:SE, Modified
Checklist for Autism in Toddlers, Mullen Scales of
Early Learning, ADOS). Thus, it is planned that a total of
500 children will receive further reference standard
assessments as described below.
The reference standard assessments will be conducted
to assess whether the current program is accurately
identifying children with ASD, global developmental
delay, physical developmental problems, and speech
and language concerns. We will also evaluate whether
the addition of the Modified Checklist for Autism in
Toddlers (M-CHAT) assessment [38] would improve
correct identification of children with ASD. The parents
will also complete the Short Temperament Scale for
Toddlers [39]. The M-CHAT, ASQ, and ASQ:SE will be
completed by the parents prior to the reference standard
assessment but the researchers carrying out the assess-
ments will be blind to the child’s scores on PEDS, M-
CHAT, ASQ, and ASQ:SE.
Reference standard assessment tools: 1) Baseline
assessment of developmental quotient will be made
using the Mullen Scales of Early Learning [40], which
is a standardised assessment of cognition from birth
to 68 months. The scales show strong and continuous
validity over time and across cultures and are widely
used with pre-school children; 2) The Autism Diagnostic
Observation Schedule 2nd edition–Toddler Module (ADOS)
[41] is a semi-structured, standardised observational
assessment of the child’s communication, social interaction,
and play. This instrument has been designed to assist in the
diagnosis of ASD, with a diagnostic algorithm generated
that is consistent with the primary diagnostic classification
systems. The instrument has excellent inter-rater agree-
ment in diagnostic classification, good test-retest reliabilityand internal consistency. To ensure the reliability of the
ADOS assessment, we will video all assessments and ten
percent of the video samples will be randomly selected and
reviewed by an independent assessor to assess inter-rater
reliability. Once all the assessments are completed, this will
be reviewed by a panel with clinical expertise in paediatrics,
psychiatry, child and family health nursing and speech
pathology as appropriate, to determine a clinical decision
about the outcome of the assessments. Families of children
identified to have features consistent with a developmental
disorder will also be provided with information about the
need for further clinical assessment. Service mapping and a
local service directory of resources will be provided along
with referrals to the local multidisciplinary assessment
clinics covering the catchment areas of the two teaching
hospitals.
Once these assessments are conducted we will calculate
the test characteristics (sensitivity, specificity, positive and
negative likelihood ratios) of 1) the PEDS alone, 2) the
current NSW surveillance program (PEDS with second
level ASQ); and 3) the PEDS plus M-CHAT by comparing
the performance of these tools, alone or in combination,
in correctly identifying children with a developmental
disorder.Power calculation
A sample size of 500 children is large compared to the
majority of previous studies exploring test performance
of developmental surveillance tools and combinations
of tools. The PEDS has been reported to have a
sensitivity and specificity of around 70 to 80% [20].
Assuming the prevalence of developmental problems
in the population is 10%, a total sample size of 449
subjects will be required to achieve a confidence interval
width of 12.5% (that is, precision) around a minimum
sensitivity of 76% [42]. A smaller sample size will be
required for a similar precision with a minimum specificity
of 75% (n = 52). Allowing for a dropout rate of approxi-
mately 10%, a total of 500 subjects will provide sufficient
experimental power.Data quality checks
A large proportion of the NBQs will be completed by the
parents at the postnatal wards at recruitment and the re-
mainder, along with the PDSQs will be completed over the
telephone. To ensure that the questions are answered in a
format that is suitable for analysis and the researchers’
questionnaire completion is consistent, each questionnaire
will be checked prior to data entry. Any missing or ambigu-
ous answers will be re-asked at a subsequent telephone call
or when researchers see the parents at the developmental
assessments.
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It is possible that we will miss some mothers in recruitment
for reasons such as: delivery during weekends or public
holidays, early discharge following delivery, and refusal to
participate in the study. Thus it is important to ascertain
the representativeness of the sample that will be recruited.
This will be done through data linkage of our cohort with
electronic medical records of all the mothers who delivered
children during the recruitment period at the two hospitals.
We will compare key socio-demographic factors such as
age, education level, indigenous background, postcode of
residence, country of birth, and languages spoken between
the mothers recruited to the project and those who are not
recruited.
Similarly, for the prospective cohort component, we
will use data linkage to compare the rates of those who
attend the 6-, 12-, and 18-month developmental checks
from the study participant group with those who are not
participants in the study. It is possible that women
who agree to participate are more aware of and engaged
with health services (including the surveillance program) as
compared to those who are not participating in the study.
Hence, relationships between various sociodemographic
factors and attendance at a 6-, 12-, and 18-month health
and/or developmental check with a healthcare professional
will also be examined using data linkage with community
nurse records. Similarly we will compare key sociode-
mographic factors for those who drop out of the study as
compared to those who continue in the study until their
infants reach 18 months of age.
Ethics
Ethical approval to perform the study has been obtained
from the University of New South Wales Human Research
Ethics Committee.
Promotion of the project
During the recruitment period, clinical and administrative
staff will be informed about the study through clinical and
research meetings as well as by displaying posters with
information about the study on the wards and waiting
rooms. A website has also been developed.
Management of project/governance
A Project Management Committee has been established
with representatives from each of the partner organisations
and quarterly meetings of this committee will provide the
forum for strategic oversight, reporting and feedback.
Further, a Research Implementation Committee has
been formed to oversee the day-to-day operational aspects
of the study. Monthly meetings will be held to discuss
issues on an ongoing basis for each of the core com-
ponents of the study, that is, qualitative focus groups,
longitudinal follow-up, and 18-month diagnostic testaccuracy components. Other stakeholders and national and
international experts will be invited to participate in the
policy translation phase.
Discussion
There have been significant advances in developing
effective and targeted interventions for developmental
disorders in the last decade but a critical challenge
remains in ensuring uptake of available developmental
surveillance services, accurate detection, and timely
referral of children at risk of, or with, identified problems
to appropriate services. The research base on these issues
is relatively limited, and often constrained by the use of
cross-sectional rather than longitudinal approaches, as well
as either qualitative or quantitative data without the
combination of these methods. Moreover, difficulties in
conducting research within ‘real-world’ health services
means that samples are often drawn from university
or other clinic settings. By seeking to address these
methodological issues in the WMG study, our hope is
to create, if you will, a three-dimensional picture of
the issue and in so doing generate detailed possibilities
for solutions.
While the developmental surveillance program rolled
out in NSW using PEDS and ASQ is an excellent example
of how early identification and follow-up pathways might
operate, the uptake of the program appears to be variable,
possibly due to a range of factors including several barriers
facing families, training limitations for professionals, and
resource constraints for health services. Further, the
linkages between such programs in the community at
the primary care level and the referral and clinical
care pathways for those identified with developmental
disorders may not be fully developed. We expect that this
study will provide considerable insight into understanding
the determinants of developmental risk as well as how
best to engage families and professionals to identify those
at risk sufficiently early to provide the best opportunities
for early intervention.
Working together with policy makers, the evidence
from the WMG study is expected to be used to improve
the uptake of developmental surveillance by addressing
the barriers from both the system and service delivery
perspective, as well as from the parental awareness,
attitudes and help seeking behaviours. Finally, the
findings from the Diagnostic Test Accuracy component of
the study will help to improve the surveillance tools and
the related processes in order to minimise the adverse
impact of false negative results from surveillance, and to
ensure optimal outcomes for children who are identified
as being at risk of a developmental disorder. The findings
on the associated individual, child, and population charac-
teristics are expected to inform ongoing planning and
delivery of the NSW surveillance program. The findings
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model with other national and international models.
Together these findings will yield an evidence base of the
risk and resilience factors determining developmental dis-
orders. The processes developed in this study for effective
partnership will also have important implications for the
ways in which future collaborations can be forged between
those in academia, service delivery, and policy making.
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